MAGE-D2 Antibodies

Santa Cruz Biotechnology provides a broad selection of MAGE-D2 monoclonal antibodies for research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MAGE-D2, a member of the MAGE (Melanoma Antigen Gene) family, plays a significant role in tumorigenesis and is often expressed in various cancers, making it a critical target for cancer immunotherapy. Understanding MAGE-D2 function can provide insights into tumor biology and the development of novel therapeutic strategies. MAGE-D2 monoclonal antibodies enable precise detection and analysis of expression patterns across different tissue types. Researchers can investigate MAGE-D2's role in cellular signaling pathways and its potential as a diagnostic marker. Advanced visualization techniques using fluorescent conjugates like phycoerythrin (PE), fluorescein isothiocyanate (FITC), and horseradish peroxidase (HRP) allow for detailed examination of MAGE-D2 localization and interactions. MAGE-D2 monoclonal antibodies support cutting-edge cancer research, helping scientists worldwide advance their understanding of tumor development and potential therapeutic interventions.